Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.

Verhoeven V, Lopez Hartmann M, Remmen R, Wens J, Apers S, Van Royen P.

BMC Complement Altern Med. 2013 Jul 18;13:178. doi: 10.1186/1472-6882-13-178.

2.

Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial.

Verhoeven V, Van der Auwera A, Van Gaal L, Remmen R, Apers S, Stalpaert M, Wens J, Hermans N.

BMC Complement Altern Med. 2015 Mar 10;15:52. doi: 10.1186/s12906-015-0576-9.

3.

Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial.

Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ.

Ann Intern Med. 2009 Jun 16;150(12):830-9, W147-9.

PMID:
19528562
4.

Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.

Becker DJ, French B, Morris PB, Silvent E, Gordon RY.

Am Heart J. 2013 Jul;166(1):187-96. doi: 10.1016/j.ahj.2013.03.019. Epub 2013 Apr 30.

PMID:
23816039
5.

Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis.

Gerards MC, Terlou RJ, Yu H, Koks CH, Gerdes VE.

Atherosclerosis. 2015 Jun;240(2):415-23. doi: 10.1016/j.atherosclerosis.2015.04.004. Epub 2015 Apr 12. Review.

6.
7.

Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.

Cicero AF, Derosa G, Parini A, Maffioli P, D'Addato S, Reggi A, Giovannini M, Borghi C.

Nutr Res. 2013 Aug;33(8):622-8. doi: 10.1016/j.nutres.2013.05.015. Epub 2013 Jul 12.

PMID:
23890351
8.

A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.

Barrat E, Zaïr Y, Ogier N, Housez B, Vergara C, Maudet C, Lescuyer JF, Bard JM, Carpentier YA, Cazaubiel M, Peltier SL.

Int J Food Sci Nutr. 2013 Nov;64(7):882-9. doi: 10.3109/09637486.2013.809405. Epub 2013 Jul 2.

PMID:
23815518
9.

HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study.

Bogsrud MP, Ose L, Langslet G, Ottestad I, Strøm EC, Hagve TA, Retterstøl K.

Scand Cardiovasc J. 2010 Aug;44(4):197-200. doi: 10.3109/14017431003624123.

PMID:
20636227
10.

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

Albert MA, Danielson E, Rifai N, Ridker PM; PRINCE Investigators.

JAMA. 2001 Jul 4;286(1):64-70.

PMID:
11434828
11.

Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.

Thomas GS, Cromwell WC, Ali S, Chin W, Flaim JD, Davidson M.

J Am Coll Cardiol. 2013 Dec 10;62(23):2178-84. doi: 10.1016/j.jacc.2013.07.081. Epub 2013 Sep 4.

13.

Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.

Sullivan D, Olsson AG, Scott R, Kim JB, Xue A, Gebski V, Wasserman SM, Stein EA.

JAMA. 2012 Dec 19;308(23):2497-506. doi: 10.1001/jama.2012.25790.

PMID:
23128163
14.

Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial.

Webster R, Li SCh, Sullivan DR, Jayne K, Su SY, Neal B.

J Med Internet Res. 2010 Sep 13;12(3):e42. doi: 10.2196/jmir.1364.

15.

Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.

Evans M, Rumberger JA, Azumano I, Napolitano JJ, Citrolo D, Kamiya T.

Vasc Health Risk Manag. 2014 Feb 27;10:89-100. doi: 10.2147/VHRM.S57116. eCollection 2014.

16.
17.

Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.

Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I.

JAMA. 2006 May 17;295(19):2262-9.

PMID:
16705107
18.

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement.

Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL.

Am J Clin Nutr. 1999 Feb;69(2):231-6.

19.

Monascus purpureus-fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet-induced hypercholesterolemic rats.

Bunnoy A, Saenphet K, Lumyong S, Saenphet S, Chomdej S.

BMC Complement Altern Med. 2015 Mar 28;15:88. doi: 10.1186/s12906-015-0624-5.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk